Based in Israel, Pluristem Therapeutics Inc. (Nasdaq, TASE: PSTI) is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, hematological disorders and exposure to radiation.